Using FDA’s ‘PIE’ Recipe to Enhance Patient Access
Published: | Updated:
How R&D organizations can leverage FDA’s final guidance on pre-approval information exchange (PIE) to engage with payers prior to approval and launch.
Dean Hakanson, Jon Gonzales, and Tara Alire
Advertisement
Dean Hakanson, Jon Gonzales, and Tara Alire
Articles by Dean Hakanson, Jon Gonzales, and Tara Alire
PIE is Good for You: Drive Patient Access by Embracing FDA's Final Guidance
Published: | Updated:
R&D organizations can leverage FDA’s final guidance on pre-approval information exchange, otherwise known as PIE, to engage with payers prior to regulatory approval and commercial launch.
Advertisement
Latest Updated Articles
PIE is Good for You: Drive Patient Access by Embracing FDA's Final GuidancePublished: July 1st 2019 | Updated: November 15th 2020
- Using FDA’s ‘PIE’ Recipe to Enhance Patient Access
Published: August 1st 2019 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
4
FDA Approves Hernexeos Under National Priority Voucher Program
5